Skip to main content
AstraZeneca PLC (LON:AZN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
14,442
-58 (-0.40%)
At close: Mar 9, 2026

AstraZeneca Revenue

In the year 2025, AstraZeneca had annual revenue of $58.74B USD with 8.63% growth. AstraZeneca had revenue of $15.50B in the quarter ending December 31, 2025, with 4.11% growth.

Revenue
$58.74B
Revenue Growth
+8.63%
P/S Ratio
5.15
Revenue / Employee
$611.23K
Employees
96,100
Market Cap
224.89B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
GSK plc 32.67B
Haleon 11.03B
Smith & Nephew 4.58B
Convatec Group 1.81B
Hikma Pharmaceuticals 2.49B
HUTCHMED (China) 407.54M
Genus 672.00M
Oxford Nanopore Technologies 223.90M
Revenue Rankings

AstraZeneca News

More News